TY - JOUR
T1 - Serotonin Transporter Distribution in the Brainstem of Multiple-System Atrophy-Parkinsonian Type
T2 - Insights from Pathology and123I-FP-CIT SPECT Findings
AU - Shang, Cong
AU - Nagao, Ryunosuke
AU - Riku, Yuichi
AU - Ichihara, Takashi
AU - Inui, Yoshitaka
AU - Ishiguro, Masanobu
AU - Tanaka, Yuumi
AU - Mizutani, Yasuaki
AU - Inoue, Masanori
AU - Iwasaki, Yasushi
AU - Yoshida, Mari
AU - Ito, Mizuki
AU - Watanabe, Hirohisa
AU - Toyama, Hiroshi
N1 - Publisher Copyright:
Copyright © 2026 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions
PY - 2026/1
Y1 - 2026/1
N2 - Studies have demonstrated loss of serotonergic neurons in the brainstems of patients with multiple-system atrophy (MSA). This study aimed to semiquantitatively investigate the status of serotonin transporter (SERT) distribution in the brainstem of individuals with MSA-parkinsonian type (MSA-P) via123I-2b-carbomethoxy-3b-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT and compare it with pathologic findings in some cases. Methods: We administered123I-FP-CIT intravenously to 19 patients with MSA-P and 17 healthy controls (HCs) and performed SPECT and MRI scans. Specific binding ratio (SBR) images were generated, and summed voxel-based SBRs for the midbrain, pons, and entire brainstem were quantified. The Mann-Whitney U test was used to compare the MSA-P and HC groups, and receiver operating characteristic curves were used to analyze the midbrain-to-pons ratio of the summed voxel-based SBR. Further, we assessed postmortem SERT immunohistochemistry pathology in the brainstems of representative MSA-P cases and HCs to comparethedistribution and densityofSERTwith SPECT findings. Results:123I-FP-CIT SPECT results revealed a significant summed voxel-based SBR decrease in the midbrain and an increase in the pons in the MSA-P group, although the brainstem summed voxelbased SBRs did not differ significantly (P, 0.05). The use of the midbrain-to-pons ratio for differentiation generated an area under the curve of 0.93. SERT immunostaining pathology, consistent with the123I-FP-CIT SPECT findings, demonstrated a significant decrease in SERT expression in the substantia nigra and a significant increase inthepontineraphenucleusin patients with MSA-P. Conclusion: Our results indicate differences in SERT distribution in the brainstems of patientswith MSA-P and HCs.
AB - Studies have demonstrated loss of serotonergic neurons in the brainstems of patients with multiple-system atrophy (MSA). This study aimed to semiquantitatively investigate the status of serotonin transporter (SERT) distribution in the brainstem of individuals with MSA-parkinsonian type (MSA-P) via123I-2b-carbomethoxy-3b-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT and compare it with pathologic findings in some cases. Methods: We administered123I-FP-CIT intravenously to 19 patients with MSA-P and 17 healthy controls (HCs) and performed SPECT and MRI scans. Specific binding ratio (SBR) images were generated, and summed voxel-based SBRs for the midbrain, pons, and entire brainstem were quantified. The Mann-Whitney U test was used to compare the MSA-P and HC groups, and receiver operating characteristic curves were used to analyze the midbrain-to-pons ratio of the summed voxel-based SBR. Further, we assessed postmortem SERT immunohistochemistry pathology in the brainstems of representative MSA-P cases and HCs to comparethedistribution and densityofSERTwith SPECT findings. Results:123I-FP-CIT SPECT results revealed a significant summed voxel-based SBR decrease in the midbrain and an increase in the pons in the MSA-P group, although the brainstem summed voxelbased SBRs did not differ significantly (P, 0.05). The use of the midbrain-to-pons ratio for differentiation generated an area under the curve of 0.93. SERT immunostaining pathology, consistent with the123I-FP-CIT SPECT findings, demonstrated a significant decrease in SERT expression in the substantia nigra and a significant increase inthepontineraphenucleusin patients with MSA-P. Conclusion: Our results indicate differences in SERT distribution in the brainstems of patientswith MSA-P and HCs.
KW - I-FP-CIT SPECT
KW - anti-SERT immunohistochemistry
KW - multiple-system atrophy
KW - selective serotonin reuptake inhibitors
KW - serotonin transporter
UR - https://www.scopus.com/pages/publications/105034928457
UR - https://www.scopus.com/pages/publications/105034928457#tab=citedBy
U2 - 10.2967/jnumed.124.268669
DO - 10.2967/jnumed.124.268669
M3 - Article
C2 - 41506799
AN - SCOPUS:105034928457
SN - 0161-5505
VL - 67
SP - 629
EP - 635
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 4
ER -